| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K33199242 |
| PharmacoGx | BRD-K33199242 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DDX21 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | TPR | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | ZNF212 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | FGF13 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | BCDIN3D | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | SUMO1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | FGF14 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | MRPL11 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | C4orf51 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | SCN1B | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
